RHHVF:OTCMKTS
Roche
$457.03
arrow_upward
+1.98%(+8.89) 1D
Okt 15, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa RHHVF...
Buksan
$448.27
Mataas
$460.00
Mababa
$448.27
Mkt. cap
369.78B
Avg. na dami
3.19K
Dami
422.00
Mataas nang 52-wk
$490.33
Mababa nang 52-wk
$318.81
Beta
0.51
Mga natitirang share
702.56M
Bilang ng mga empleyado
113K
Buksan
$448.27
Mataas
$460.00
Mababa
$448.27
Mkt. cap
369.78B
Avg. na dami
3.19K
Dami
422.00
Mataas nang 52-wk
$490.33
Mababa nang 52-wk
$318.81
Beta
0.51
Mga natitirang share
702.56M
Bilang ng mga empleyado
113K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Reuters
·
2 araw ang nakalipas
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
Euronext Markets: Real-time Stock Market Data | live
·
2 araw ang nakalipas
Roche strikes obesity drug licensing deal worth up to $1.16 billion with Chinese Rona Therapeutics
ad-hoc-news.de
·
2 araw ang nakalipas
Roche Holding stock rises 3.44 percent on SIX
The Globe and Mail
·
2 araw ang nakalipas
Analysts Offer Insights on Healthcare Companies: Nektar Therapeutics (NKTR), Roche Holding AG (OtherRHHVF) and Henry Schein (HSIC)
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
Tungkol sa Roche
CEOThomas Schinecker
Mga Empleyado113K
ItinatagOkt 1, 1896
HeadquartersBasel, Basel City, Switzerland
Sektor-
Websiteroche.com